Century Therapeutics Long-Term Investments

As of the most recent data (June 2026), IPSC shows a long-term investments of $77M. That compares with $2.7M in the prior-year period — up 2780.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IPSC's long-term investments is now $77M (was $2.7M) — a 2780.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Century Therapeutics is outperforming or lagging.

Tracking IPSC's long-term investments over time shows whether Century Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $77M That compares with $2.7M in the prior-year period — up 2780.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term investments page, Stockcircle has Century Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term investments (currently $77M) with ownership activity and broader fundamentals.

Century Therapeutics's long-term investments is $77M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.